Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evidence of an Association of Increases in Pre-exposure Prophylaxis Coverage With Decreases in Human Immunodeficiency Virus Diagnosis Rates in the United States, 2012-2016.
Smith DK, Sullivan PS, Cadwell B, Waller LA, Siddiqi A, Mera-Giler R, Hu X, Hoover KW, Harris NS, McCallister S. Smith DK, et al. Among authors: mccallister s. Clin Infect Dis. 2020 Dec 15;71(12):3144-3151. doi: 10.1093/cid/ciz1229. Clin Infect Dis. 2020. PMID: 32097453 Free PMC article.
Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.
Sullivan PS, Giler RM, Mouhanna F, Pembleton ES, Guest JL, Jones J, Castel AD, Yeung H, Kramer M, McCallister S, Siegler AJ. Sullivan PS, et al. Among authors: mccallister s. Ann Epidemiol. 2018 Dec;28(12):833-840. doi: 10.1016/j.annepidem.2018.06.009. Epub 2018 Jun 22. Ann Epidemiol. 2018. PMID: 30037634 Free PMC article.
The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.
Siegler AJ, Mouhanna F, Giler RM, Weiss K, Pembleton E, Guest J, Jones J, Castel A, Yeung H, Kramer M, McCallister S, Sullivan PS. Siegler AJ, et al. Among authors: mccallister s. Ann Epidemiol. 2018 Dec;28(12):841-849. doi: 10.1016/j.annepidem.2018.06.005. Epub 2018 Jun 15. Ann Epidemiol. 2018. PMID: 29983236 Free PMC article.
Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques.
Massud I, Cong ME, Ruone S, Holder A, Dinh C, Nishiura K, Khalil G, Pan Y, Lipscomb J, Johnson R, Deyounks F, Rooney JF, Babusis D, Park Y, McCallister S, Callebaut C, Heneine W, García-Lerma JG. Massud I, et al. Among authors: mccallister s. J Infect Dis. 2019 Oct 22;220(11):1826-1833. doi: 10.1093/infdis/jiz383. J Infect Dis. 2019. PMID: 31362305
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Mayer KH, Molina JM, Thompson MA, Anderson PL, Mounzer KC, De Wet JJ, DeJesus E, Jessen H, Grant RM, Ruane PJ, Wong P, Ebrahimi R, Zhong L, Mathias A, Callebaut C, Collins SE, Das M, McCallister S, Brainard DM, Brinson C, Clarke A, Coll P, Post FA, Hare CB. Mayer KH, et al. Among authors: mccallister s. Lancet. 2020 Jul 25;396(10246):239-254. doi: 10.1016/S0140-6736(20)31065-5. Lancet. 2020. PMID: 32711800 Free PMC article. Clinical Trial.
61 results